As the largest market for particle size and distribution analysis, the pharmaceutical industry accounted for approximately 15% of the sales of instruments and aftermarket products last year. Particle size is a crucial metric for the design, quality control and manufacturing of pharmaceuticals. In developing new drugs, researchers are increasingly exploring the use of nano-sized particles […]
In the first of IBO’s twice yearly look at new labs, IBO covers new laboratory construction in China and Singapore, along with new laboratories in the nanotechnology sector, particularly on US college campuses. IBO’s report ends with a look at oil money’s advancement of new laboratory construction in the Middle East. Foreign multinational investment in […]
R&D spending may be on the rise in Turkey due to a new measure that lets companies deduct all of their R&D spending from their tax base until 2024, an increase from the previously allowed 40% tax deduction. The law was passed to stimulate exports of technological products and to attract multinational R&D. To be […]
According to the “2008 Pharmaceutical Industry Profile” released by the Pharmaceutical Research and Manufacturers of America (PhRMA), R&D spending by PhRMA-member companies rose 2.5% to $44.530 billion in 2007. Member companies’ 2007 sales increased 6.6% to $271.515 billion. As a result, R&D as a percentage of sales was 16.4%, down from 17.1% in 2006. In […]
The credit crisis could affect the ability of biotech companies worldwide to raise new funding. Although venture capital funding for biotech did not slow last year, some observers believe the criteria for such investments will become stricter and competition between late- and early-stage companies for such funding could increase. Last year, funding for biotech and […]
The EU is continuing its focus on maintaining its position as a top ranking R&D region. According to Eurostat, the UK, Germany and France were responsible for approximately 60% of total R&D expenditure in the EU in 2006. For that year, 1.84% of the EU’s GDP, €212 billion ($265 billion), was spent on R&D. The […]
Global food sales grew an average of 1.8% last year, hampered by price increases for most staple items, including milk, eggs, corn and wheat. Food producers have also been impacted by higher electricity and fuel costs, part of what one analyst described as a “perfect storm” for the industry. In 2007, Kraft spent $1.3 billion […]
A $1 billion project to decode the DNA of 100,000 people will be undertaken by Harvard University scientist George Church with the backing of Google and OrbiMed Advisors. Dr. Church’s project will focus on tying each subject’s DNA to their health history in order to create a database with which to develop new medicines. The […]
According to Semiconductor Equipment and Materials International (SEMI), the semiconductor industry experienced its second best year ever in 2007,with worldwide sales for semiconductor manufacturing equipment of $42.77 billion, a 6% increase from 2006. Experts believe this increase is due to both the growth of the 300 mm ramp and intensive memory investments. The statistics are […]
In 2007, Egypt imported $40 million of biotechnology laboratory equipment, and the market is expected grow 10% per year. The government’s five-year plan for 2007–2012 will spend $800 million to upgrade equipment in scientific research centers. In addition, the plan sets aside $5.3 billion for agriculture, including the development of biotech-based crops, and $5.1 billion […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
